Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D05VEV
|
||||
Former ID |
DNC006566
|
||||
Drug Name |
Ac-hPhe-Leu-Ala-LeuVSMe
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [1] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C29H46N4O6S
|
||||
Canonical SMILES |
CC(C)CC(C=CS(=O)(=O)C)NC(=O)C(C)NC(=O)C(CC(C)C)NC(=O)C(<br />CCC1=CC=CC=C1)NC(=O)C
|
||||
InChI |
1S/C29H46N4O6S/c1-19(2)17-24(15-16-40(7,38)39)32-27(35)21(5)30-29(37)26(18-20(3)4)33-28(36)25(31-22(6)34)14-13-23-11-9-8-10-12-23/h8-12,15-16,19-21,24-26H,13-14,17-18H2,1-7H3,(H,30,37)(H,31,34)(H,32,35)(H,33,36)/b16-15+/t21-,24+,25-,26-/m0/s1
|
||||
InChIKey |
WUQZWLVEKPBGGU-WXIXLNPNSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Cathepsin B | Target Info | Inhibitor | [1] | |
Cathepsin S | Target Info | Inhibitor | [1] | ||
KEGG Pathway | Lysosome | ||||
Antigen processing and presentationhsa04142:Lysosome | |||||
Phagosome | |||||
Antigen processing and presentation | |||||
Tuberculosis | |||||
NetPath Pathway | TCR Signaling Pathway | ||||
IL2 Signaling PathwayNetPath_22:Leptin Signaling Pathway | |||||
IL2 Signaling Pathway | |||||
Reactome | Collagen degradation | ||||
Trafficking and processing of endosomal TLR | |||||
Assembly of collagen fibrils and other multimeric structures | |||||
MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
Degradation of the extracellular matrix | |||||
MHC class II antigen presentation | |||||
WikiPathways | Class I MHC mediated antigen processing & presentation | ||||
Trafficking and processing of endosomal TLR | |||||
References | |||||
REF 1 | J Med Chem. 2006 May 18;49(10):2953-68.Optimization of subsite binding to the beta5 subunit of the human 20S proteasome using vinyl sulfones and 2-keto-1,3,4-oxadiazoles: syntheses and cellular properties of potent, selective proteasome inhibitors. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.